Davidson Kempner Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Davidson Kempner Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,284,855	Closed	-$13M	–	182
2018 Q3	$13M	Sell	1,284,855 -15,245	-1%	-$154K	0.14%	105
2018 Q2	$13M	Sell	1,300,100 -50,000	-4%	-$501K	0.15%	126
2018 Q1	$13.4M	Sell	1,350,100 -14,900	-1%	-$148K	0.14%	101
2017 Q4	$13.5M	Hold	1,365,000	–	–	0.18%	98
2017 Q3	$13.6M	Buy	+1,365,000	New	+$13.5M	0.18%	94

Davidson Kempner Capital Management's ORGO Position: Q4 2018 in Review

Davidson Kempner Capital Management sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 1,284,855 shares — an estimated $13M sold.

Davidson Kempner Capital Management first reported a position in ORGO in Q3 2017 and held it in 5 quarters. The position peaked at $13.6M in Q3 2017. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

Davidson Kempner Capital Management reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
Davidson Kempner Capital Management sold 1,284,855 Organogenesis Holdings shares in Q4 2018, an estimated $13M.
Davidson Kempner Capital Management first reported a position in Organogenesis Holdings in Q3 2017 and held it in 5 quarters.
Davidson Kempner Capital Management's Organogenesis Holdings position peaked at $13.6M in Q3 2017.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.